These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1181689)

  • 1. Hong Kong Tuberculosis Treatment Services/British Medical Research Council study of short-course regimens of streptomycin, isoniazid and pyrazinamide: latest results.
    Girling DJ
    Tubercle; 1975 Jun; 56(2):165-6. PubMed ID: 1181689
    [No Abstract]   [Full Text] [Related]  

  • 2. Hong Kong tuberculosis treatment services/British Medical Research Council Study of 6- and 9-month regimens of daily and intermittent streptomycin, isoniazid and pyrazinamide for pulmonary tuberculosis.
    Allan WG
    Bull Int Union Tuberc; 1976; 51(1):91-3. PubMed ID: 1030317
    [No Abstract]   [Full Text] [Related]  

  • 3. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):700-6. PubMed ID: 1901199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controlled trial of 6 to 8 month chemotherapeutic regimens in the treatment of pulmonary tuberculosis. A study of Hong Kong Chest Service/British Medical Research Council/].
    Aquinas M
    Bull Int Union Tuberc; 1978 Dec; 53(4):253. PubMed ID: 387136
    [No Abstract]   [Full Text] [Related]  

  • 5. Controlled trial of 6-month and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong. The results up to 30 months.
    Am Rev Respir Dis; 1977 May; 115(5):727-35. PubMed ID: 857713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effectiveness and problems of PZA-containing 6-month regimen for the treatment of new pulmonary tuberculosis patients].
    Wada M
    Kekkaku; 2001 Jan; 76(1):33-43. PubMed ID: 11211781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trial of 6- and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong.
    Tubercle; 1975 Jun; 56(2):81-96. PubMed ID: 1103400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of a daily combined preparation of isoniazid, rifampin, and pyrazinamide in a controlled trial of three 6-month regimens for smear-positive pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.
    Am Rev Respir Dis; 1991 Apr; 143(4 Pt 1):707-12. PubMed ID: 1901200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-course (6-month) treatment of pulmonary tuberculosis (Second East African/British Medical Research Council Study).
    Jindani A
    Bull Int Union Tuberc; 1976; 51(1):53-6. PubMed ID: 71178
    [No Abstract]   [Full Text] [Related]  

  • 10. A controlled trial of 3-month, 4-month, and 6-month regimens of chemotherapy for sputum-smear-negative pulmonary tuberculosis. Results at 5 years. Hong Kong Chest Service/Tuberculosis Research Centre, Madras/British Medical Research Council.
    Am Rev Respir Dis; 1989 Apr; 139(4):871-6. PubMed ID: 2648911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
    Lancet; 1974 Nov; 2(7889):1100-6. PubMed ID: 4139405
    [No Abstract]   [Full Text] [Related]  

  • 12. Short-course chemotherapy for tuberculosis.
    Pearson JO
    Lancet; 1979 Aug; 2(8139):420. PubMed ID: 89476
    [No Abstract]   [Full Text] [Related]  

  • 13. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. First report of 4th study. East African and British Medical Research Councils.
    Lancet; 1978 Aug; 2(8085):334-8. PubMed ID: 79708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proceedings: Latest results of East African/British Medical Research Council short course chemotherapy studies.
    Heffernan JF
    Tubercle; 1975 Jun; 56(2):165. PubMed ID: 1181688
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of various drug regimens in domiciliary chemotherapy.
    Mehrotra ML; Pande DC; Grover KL; Gautam KD
    Am Rev Respir Dis; 1970 Oct; 102(4):607-13. PubMed ID: 4195520
    [No Abstract]   [Full Text] [Related]  

  • 16. Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis. First report.
    Am Rev Respir Dis; 1978 Aug; 118(2):219-28. PubMed ID: 100029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-course chemotherapy for pulmonary tuberculosis. Points of interest.
    Zabow M; Pearson JO
    S Afr Med J; 1982 Jun; 61(23):867-70. PubMed ID: 7079914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled clinical trial of five short-course (4-month) chemotherapy regimens in pulmonary tuberculosis. Second report of the 4th study. East African/British Medical Research Councils Study.
    Am Rev Respir Dis; 1981 Feb; 123(2):165-70. PubMed ID: 7015933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four regimens of streptomycin plus pyrazinamide in retreatment: East African-British Medical Research Council investigation.
    Stott H
    Bull Int Union Tuberc; 1970 Jun; 43():261-8. PubMed ID: 5425552
    [No Abstract]   [Full Text] [Related]  

  • 20. [Short-course chemotherapy of tuberculosis with pyrazinamide].
    Asai S; Futsuki Y; Tomari S; Araki J
    Nihon Rinsho; 1998 Dec; 56(12):3087-90. PubMed ID: 9883615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.